Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
D

Failure to Document Monitoring for Anticoagulant Therapy

Torrance, California Survey Completed on 08-08-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

Nursing staff failed to document monitoring for signs and symptoms of bleeding on the medication administration record (MAR) for a resident who was prescribed Apixaban, an anticoagulant. The resident had multiple diagnoses, including hypotension, hyperlipidemia, and atrial flutter, and was dependent on staff for all activities of daily living. The care plan required monitoring and documentation of bleeding every shift due to the use of Apixaban, but this was not completed or recorded on the MAR as required. During interviews, both the LVN and RN confirmed that monitoring for bleeding and bruising was not being documented, and the Director of Nursing acknowledged that this documentation should have been present on the MAR. Review of facility policy indicated that licensed nurses are required to monitor and document for signs and symptoms related to high-risk medications, including Apixaban, and to inform the attending physician of any findings. The lack of documentation indicated that the required monitoring was not performed.

An unhandled error has occurred. Reload 🗙